You’re in the middle of a long question block, you see fasting, hypoglycemia, and a whiff of liver metabolism, and suddenly the stem pivots to “key gluconeogenesis enzymes.” This is a classic USMLE setup: one correct enzyme—plus a handful of answer choices that are almost right unless you know exactly where gluconeogenesis happens, what bypass steps exist, and which hormones push the pathway.
Tag: Biochemistry > Bioenergetics & Carb Metabolism
The Clinical Vignette (Q-bank style)
A 6-month-old infant is brought to the ED for lethargy and poor feeding after a viral illness. Parents report the child has been vomiting and has not eaten much for the past 18 hours. Exam shows tachycardia and mild hepatomegaly. Point-of-care glucose is 38 mg/dL. Labs show:
- High ketones
- Elevated lactate
- Low insulin, high glucagon
- Normal oxygenation and blood pressure
A genetic test later reveals a deficiency in a hepatic enzyme required to bypass an irreversible step of glycolysis during gluconeogenesis.
Which enzyme is most likely deficient?
A. Hexokinase
B. Phosphofructokinase-1 (PFK-1)
C. Fructose-1,6-bisphosphatase
D. Pyruvate kinase
E. Glycogen phosphorylase
Step 1: Identify the Tested Concept
Gluconeogenesis is not “glycolysis in reverse.” It requires bypass enzymes for the three irreversible glycolysis steps:
| Irreversible glycolysis step | Glycolysis enzyme | Gluconeogenesis bypass enzyme(s) |
|---|---|---|
| Glucose → Glucose-6-P | Hexokinase / Glucokinase | Glucose-6-phosphatase |
| Fructose-6-P → Fructose-1,6-bisP | PFK-1 | Fructose-1,6-bisphosphatase |
| PEP → Pyruvate | Pyruvate kinase | Pyruvate carboxylase + PEP carboxykinase (PEPCK) |
The vignette says: deficiency of an enzyme required to bypass an irreversible glycolysis step during gluconeogenesis → think one of the bypass enzymes, not the glycolysis enzymes.
Correct Answer: C. Fructose-1,6-bisphosphatase
Why this fits the stem
Fructose-1,6-bisphosphatase (FBPase-1) converts:
This is the gluconeogenic bypass of the PFK-1 step, which is irreversible in glycolysis.
High-yield clinical tie-ins
FBPase-1 deficiency is a classic cause of fasting intolerance:
- Severe fasting hypoglycemia
- Lactic acidosis (pyruvate gets shunted to lactate when gluconeogenesis is impaired)
- Often worsens during illness or prolonged fasting
- Ketosis may be present because fatty acid oxidation still supplies energy and drives ketone formation (but glucose production is impaired)
Regulation (testable!)
FBPase-1 is:
- Inhibited by AMP (signals low energy → favor glycolysis)
- Inhibited by fructose-2,6-bisphosphate (the big “switch” molecule)
- Activated by citrate (signals abundant energy → favor gluconeogenesis)
Insulin increases fructose-2,6-bisphosphate (via PFK-2 activity) → inhibits FBPase-1 → decreases gluconeogenesis.
Glucagon decreases fructose-2,6-bisphosphate (via phosphorylation of PFK-2/FBPase-2) → disinhibits FBPase-1 → increases gluconeogenesis.
Now, Why Every Distractor Is Wrong (and what they’re trying to trick you into)
A. Hexokinase — Wrong (and the nuance matters)
Hexokinase catalyzes the first step of glycolysis in most tissues:
But gluconeogenesis bypasses this with glucose-6-phosphatase, which is mainly in liver and kidney (and absent in muscle). Hexokinase deficiency is not the typical fasting hypoglycemia vignette.
High-yield differentiator:
- Hexokinase: high affinity (low ), inhibited by G6P, present in many tissues
- Glucokinase (liver, pancreatic β-cells): lower affinity (high ), induced by insulin
If the question wanted the bypass enzyme for this step, the correct answer would be glucose-6-phosphatase (not listed).
B. Phosphofructokinase-1 (PFK-1) — Wrong, but common trap
PFK-1 is the rate-limiting enzyme of glycolysis, not gluconeogenesis:
A PFK-1 problem points you toward Tarui disease (GSD VII):
- Exercise intolerance
- Muscle cramps
- Myoglobinuria
- Hemolysis (RBCs rely heavily on glycolysis)
That clinical picture is very different from fasting hypoglycemia + lactic acidosis due to impaired hepatic glucose output.
High-yield regulation:
- PFK-1 is activated by AMP and fructose-2,6-bisphosphate
- Inhibited by ATP and citrate
The stem is about the bypass of PFK-1 → that’s FBPase-1, the correct answer.
D. Pyruvate kinase — Wrong (but know what it causes)
Pyruvate kinase catalyzes the last irreversible step of glycolysis:
Deficiency classically causes hemolytic anemia because RBCs depend entirely on glycolysis for ATP:
- Extravascular hemolysis
- Increased 2,3-BPG → right shift of O2 dissociation curve
- Jaundice, splenomegaly
That is not a liver gluconeogenesis defect presentation.
Also, gluconeogenesis bypasses pyruvate kinase using pyruvate carboxylase + PEPCK (two-step bypass). If those were answer choices, they’d be contenders.
E. Glycogen phosphorylase — Wrong for this question, but clinically relevant
Glycogen phosphorylase breaks down glycogen:
Defects cause glycogen storage diseases depending on isoenzyme/tissue:
- McArdle disease (muscle phosphorylase, GSD V): exercise intolerance, cramps, myoglobinuria, “second wind”
- Hers disease (liver phosphorylase, GSD VI): mild fasting hypoglycemia, hepatomegaly
This stem emphasizes a block in gluconeogenesis bypass of glycolysis, plus lactic acidosis, which leans away from isolated glycogenolysis defects and toward impaired conversion of precursors into glucose.
USMLE pearl: In early fasting, glycogenolysis predominates; with prolonged fasting, gluconeogenesis becomes essential. A sick infant who can’t maintain glucose after fasting is a common setup for inborn errors affecting these pathways.
The “Big Picture” Algorithm for These Questions
When you see fasting hypoglycemia, quickly sort:
1) Is it a glycogen problem or a gluconeogenesis problem?
- Glycogen storage diseases often have hepatomegaly; lactate may be high in some (notably von Gierke, due to inability to release free glucose).
- Gluconeogenesis defects often show lactic acidosis because pyruvate can’t be routed to glucose efficiently.
2) Which irreversible step is being bypassed?
Just memorize the three bypass enzymes:
- Glucose-6-phosphatase (ER lumen; liver/kidney)
- Fructose-1,6-bisphosphatase (cytosol)
- Pyruvate carboxylase (mitochondria) + PEPCK (cytosol/mito)
3) Use hormone logic
- Glucagon/epinephrine/cortisol → increase gluconeogenesis
- Insulin → decrease gluconeogenesis
Key switch: fructose-2,6-bisphosphate - High F-2,6-bisP → glycolysis ON (PFK-1 activated), gluconeogenesis OFF (FBPase-1 inhibited)
Rapid-Fire High-Yield Facts (USMLE-ready)
- Gluconeogenesis substrates: lactate (Cori cycle), alanine (glucose-alanine cycle), glycerol (from triglycerides)
- Odd-chain fatty acids → propionyl-CoA → succinyl-CoA → can contribute to gluconeogenesis
(Even-chain fatty acids cannot yield net glucose via acetyl-CoA.) - Pyruvate carboxylase requires biotin (B7) and is activated by acetyl-CoA
- PEPCK uses GTP
- Gluconeogenesis costs energy: to make 1 glucose from 2 pyruvate:
Takeaway
The stem screams “bypass an irreversible glycolysis step during gluconeogenesis,” and the correct bypass enzyme for the PFK-1 step is fructose-1,6-bisphosphatase. The distractors are high-yield because they anchor the irreversible glycolysis steps and the related clinical syndromes (RBC hemolysis, muscle glycogenoses, etc.)—but they’re not the enzymes that run gluconeogenesis.
Frequently Asked Questions
What enzyme deficiency causes fasting hypoglycemia with high ketones and elevated lactate in gluconeogenesis?
Fructose-1,6-bisphosphatase deficiency best fits fasting hypoglycemia with ketosis and elevated lactate. This enzyme converts fructose-1,6-bisphosphate to fructose-6-phosphate during gluconeogenesis and bypasses the irreversible PFK-1 step of glycolysis. When it is deficient, hepatic glucose production falls during fasting, pyruvate is shunted to lactate, and symptoms often worsen during illness or prolonged fasting.
How do you tell a gluconeogenesis bypass enzyme from a glycolysis enzyme on a question stem?
The key clue is whether the stem asks about bypassing an irreversible glycolysis step during gluconeogenesis. Gluconeogenesis is not simply glycolysis in reverse, so it uses special bypass enzymes instead of the glycolytic enzymes themselves. The relevant bypasses are glucose-6-phosphatase for hexokinase or glucokinase, fructose-1,6-bisphosphatase for PFK-1, and pyruvate carboxylase plus PEP carboxykinase for pyruvate kinase.
Why does fructose-1,6-bisphosphatase deficiency cause lactic acidosis?
It causes lactic acidosis because impaired gluconeogenesis shunts pyruvate toward lactate instead of allowing normal glucose production. Fructose-1,6-bisphosphatase is required for the gluconeogenic bypass of the irreversible PFK-1 step. When that pathway is blocked, fasting hepatic glucose output drops and lactate accumulates, especially during prolonged fasting or illness.
How is fructose-1,6-bisphosphatase regulated by insulin and glucagon?
Fructose-1,6-bisphosphatase is inhibited by fructose-2,6-bisphosphate, so insulin decreases its activity and glucagon increases it indirectly. Insulin raises fructose-2,6-bisphosphate via PFK-2 activity, which inhibits fructose-1,6-bisphosphatase and decreases gluconeogenesis. Glucagon lowers fructose-2,6-bisphosphate through phosphorylation of PFK-2/FBPase-2, which disinhibits fructose-1,6-bisphosphatase and promotes gluconeogenesis.
How do you distinguish fructose-1,6-bisphosphatase deficiency from PFK-1 or pyruvate kinase deficiency on exams?
Fructose-1,6-bisphosphatase deficiency points to fasting intolerance with severe hypoglycemia and lactic acidosis, reflecting impaired hepatic gluconeogenesis. In contrast, PFK-1 deficiency suggests Tarui disease with exercise intolerance, muscle cramps, myoglobinuria, and hemolysis. Pyruvate kinase deficiency classically causes hemolytic anemia with jaundice and splenomegaly because red blood cells depend entirely on glycolysis for ATP.